Susquehanna International Group’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

Susquehanna International Group’s Portfolio LMNL Stock Details LMNL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,400	Closed	-$32K	–	14184
2021 Q3	$32K	Sell	1,400 -390	-22%	-$11.2K	﹤0.01%	12479
2021 Q2	$70K	Buy	+1,790	New	+$78K	﹤0.01%	12224

Other funds holding LMNL

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ECM

Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Susquehanna International Group's LMNL Position: Q2 2023 in Review

Susquehanna International Group sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q2 2023, closing a stake of 14,133 shares — an estimated $53.7K sold.

Susquehanna International Group first reported a position in LMNL in Q2 2021 and held it in 5 quarters. The position peaked at $173K in Q2 2021. 8 funds tracked by Wall St. Rank hold LMNL as of Q2 2023.

Susquehanna International Group reported no remaining Liminal BioSciences Inc. Common Shares position as of Q2 2023 after selling out during the quarter.
Susquehanna International Group sold 14,133 Liminal BioSciences Inc. Common Shares shares in Q2 2023, an estimated $53.7K.
Susquehanna International Group first reported a position in Liminal BioSciences Inc. Common Shares in Q2 2021 and held it in 5 quarters.
Susquehanna International Group's Liminal BioSciences Inc. Common Shares position peaked at $173K in Q2 2021.
8 funds tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.